Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03646825
Other study ID # 20170532
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date August 1, 2018
Est. completion date October 1, 2022

Study information

Verified date February 2023
Source Colorado Center for Reproductive Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Observational study to see the effect of use of natural Antioxidant supplement on sperm DNA fragmentation. Subjects will take the natural antioxidant for 3 months prior to repeat testing.


Description:

Male patients will be recruited based on having a high DNA fragmentation (chromatin >16) no other severe male factor infertility (>5million/ml, count, > 10%motility and >1% morphology) and sufficient ejaculate sperm for ICSI (no surgically removed sperm or history of vasectomy reversal). Patients will be provided the natural antioxidant supplementation by the sponsor. Patients will take 1 capsule orally 3 times a day for a full 12 weeks. Sperm DNA structure will be re-assessed after completion of 12 weeks of antioxidant to compare to baseline sperm DNA structure collected prior to starting regimen of supplement daily


Recruitment information / eligibility

Status Terminated
Enrollment 54
Est. completion date October 1, 2022
Est. primary completion date June 15, 2022
Accepts healthy volunteers
Gender Male
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: -Sperm Chromatin >16%, sufficient ejaculate sperm for ICSI Exclusion Criteria: - Severe male factor infertility

Study Design


Related Conditions & MeSH terms

  • Observe Effect of Antioxidant on Sperm DNA Fragmention

Intervention

Dietary Supplement:
Natural Antioxidant supplement
1 capsule orally three times a day for 12 weeks

Locations

Country Name City State
United States Colorado Center for Reproductive Medicine Lone Tree Colorado

Sponsors (1)

Lead Sponsor Collaborator
Colorado Center for Reproductive Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sperm DNA fragmentation Direct comparison of sperm DNA fragmentation pre and post natural antioxidant exposure 12 weeks